Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2024

Nov 5, 2024

29745_dirs_2024-11-05_84c6ec94-8172-4b49-af1d-8e631ed8060a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2024-11-01

Reporting Person: Dozier Eric (EVP, HR & Diversity)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-11-01 Common Stock M 1534 Acquired 8724 Direct
2024-11-01 Common Stock F 681.403 $818.93 Disposed 8042.597 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-11-01 Restricted Stock Unit $ M 1534 Disposed 2024-11-01 Common Stock (1534) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 291.66 Indirect

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.